118 related articles for article (PubMed ID: 10933870)
1. Polymerase chain reaction-single-strand conformation polymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the Japanese population.
Itoh K; Inoue K; Nakao H; Yanagiwara S; Tada H; Suzuki T
Anal Biochem; 2000 Aug; 284(1):160-2. PubMed ID: 10933870
[No Abstract] [Full Text] [Related]
2. [The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].
Lou YQ; Kuang TY
Sheng Li Ke Xue Jin Zhan; 1995 Jan; 26(1):23-8. PubMed ID: 7604218
[TBL] [Abstract][Full Text] [Related]
3. A rapid and simple detection of genetic defects responsible for the phenotypic polymorphism of cytochrome P450 2C19.
Itoh K; Inoue K; Yanagiwara S; Kyoya H; Suzuki T
Biol Pharm Bull; 1999 Jan; 22(1):77-9. PubMed ID: 9989666
[TBL] [Abstract][Full Text] [Related]
4. [Cytochrome P450 2C19 gene polymorphism in four Chinese nationality populations].
Zhang S; Dong Z; Tang L; Zhou Q; Wu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):52-4. PubMed ID: 11836688
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms in the cytochrome P450 (CYP) 2C19 and 2C18 genes in Japanese epileptic patients.
Mamiya K; Ieiri I; Miyahara S; Imai J; Furuumi H; Fukumaki Y; Ninomiya H; Tashiro N; Yamada H; Higuchi S
Pharmacogenetics; 1998 Feb; 8(1):87-90. PubMed ID: 9511186
[No Abstract] [Full Text] [Related]
6. Detection of CYP2C19 alleles *1, *2 and *3 by multiplex polymerase chain reaction.
Griese EU; Läpple F; Eichelbaum M
Pharmacogenetics; 1999 Jun; 9(3):389-91. PubMed ID: 10471071
[No Abstract] [Full Text] [Related]
7. Linkage of mutant alleles of CYP2C18 and CYP2C19 in a Japanese population.
Kubota T; Hibi N; Chiba K
Biochem Pharmacol; 1998 Jun; 55(12):2039-42. PubMed ID: 9714325
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.
Mochizuki J; Murakami S; Sanjo A; Takagi I; Akizuki S; Ohnishi A
J Gastroenterol Hepatol; 2005 Aug; 20(8):1191-7. PubMed ID: 16048566
[TBL] [Abstract][Full Text] [Related]
9. Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.
Goldstein JA; Blaisdell J
Methods Enzymol; 1996; 272():210-8. PubMed ID: 8791779
[No Abstract] [Full Text] [Related]
10. Genetic polymorphism of cytochrome P450 and methods for its determination.
Buzková H; Pechandová K; Slanar O; Perlík F
Prague Med Rep; 2006; 107(4):383-93. PubMed ID: 17402551
[TBL] [Abstract][Full Text] [Related]
11. [Progress in the studies on the CYP2C19 polymorphism].
He N; Zhou HH
Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):171-4. PubMed ID: 12889158
[No Abstract] [Full Text] [Related]
12. A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin.
Ibeanu GC; Blaisdell J; Ferguson RJ; Ghanayem BI; Brosen K; Benhamou S; Bouchardy C; Wilkinson GR; Dayer P; Goldstein JA
J Pharmacol Exp Ther; 1999 Aug; 290(2):635-40. PubMed ID: 10411572
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.
Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H
Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825
[TBL] [Abstract][Full Text] [Related]
14. High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.
Kaneko A; Kaneko O; Taleo G; Björkman A; Kobayakawa T
Lancet; 1997 Mar; 349(9056):921-2. PubMed ID: 9093256
[No Abstract] [Full Text] [Related]
15. Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe.
Masimirembwa C; Bertilsson L; Johansson I; Hasler JA; Ingelman-Sundberg M
Clin Pharmacol Ther; 1995 Jun; 57(6):656-61. PubMed ID: 7781265
[TBL] [Abstract][Full Text] [Related]
16. Genotype analysis of the CYP2C19 gene in HCV-seropositive patients with cirrhosis and hepatocellular carcinoma.
Chau TK; Marakami S; Kawai B; Nasu K; Kubota T; Ohnishi A
Life Sci; 2000 Aug; 67(14):1719-24. PubMed ID: 11021356
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus.
Imai J; Ieiri I; Mamiya K; Miyahara S; Furuumi H; Nanba E; Yamane M; Fukumaki Y; Ninomiya H; Tashiro N; Otsubo K; Higuchi S
Pharmacogenetics; 2000 Feb; 10(1):85-9. PubMed ID: 10739176
[No Abstract] [Full Text] [Related]
18. Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient.
Furuta T; Takashima M; Shirai N; Xiao F; Hanai H; Ohashi K; Ishizaki T
Clin Pharmacol Ther; 2000 Jun; 67(6):684-9. PubMed ID: 10872651
[TBL] [Abstract][Full Text] [Related]
19. A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin.
Ferguson RJ; De Morais SM; Benhamou S; Bouchardy C; Blaisdell J; Ibeanu G; Wilkinson GR; Sarich TC; Wright JM; Dayer P; Goldstein JA
J Pharmacol Exp Ther; 1998 Jan; 284(1):356-61. PubMed ID: 9435198
[TBL] [Abstract][Full Text] [Related]
20. Association between CYP2A6 and CYP2C19 mutant alleles.
Lam K; Chow L; Leung T; Wing YK; Chiu HF; Garcia-Barceló M
Clin Pharmacol Ther; 1999 Dec; 66(6):647. PubMed ID: 10613622
[No Abstract] [Full Text] [Related]
[Next] [New Search]
